Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, you can eat too little on Mounjaro, and it matters more than most people expect. Tirzepatide suppresses appetite strongly enough that some people drop well below 1,000 calories a day without intending to — and that can slow muscle preservation, trigger nutrient deficiencies, and make side effects harder to tolerate. These are prescription-only medicines requiring clinical assessment; what you eat on treatment is something your prescriber or dietitian should know about. The sections below explain why eating too little on Mounjaro is a real clinical concern, what the signs look like, and how to keep intake in a range that actually supports the weight loss you're aiming for.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It sounds logical. Mounjaro cuts your appetite; you eat far less; you lose weight quickly. Simple. The problem is that this reasoning treats all calorie cuts as equal, and they are not.
When intake drops very low (below roughly 800 to 1,000 calories a day for most adults) the body increasingly turns to muscle for fuel alongside fat. Lean mass is metabolically expensive tissue; the body sacrifices it readily when it senses scarcity. That matters because muscle is the engine of your resting metabolic rate. Losing it while losing weight sets up a slower metabolism that makes maintaining any loss harder once treatment ends.
The NHS notes that weight-loss programmes work best when they preserve muscle alongside reducing fat, and that protein intake is a key part of that. Tirzepatide does not override this biology, it changes how hungry you feel, not how your body handles a severe deficit. So the goal on Mounjaro is not the lowest possible calorie intake. It is a moderate, sustainable deficit that comes with adequate protein, enough fibre to support digestion, and enough fluid to offset the dehydration risk that already exists with GI side effects. You can read more about what to prioritise in your diet on Mounjaro in our dedicated guide.
A lot of people find this counterintuitive, if your appetite has essentially vanished, forcing yourself to eat more feels strange. That feeling is worth naming, not dismissing.
The signs are not always dramatic. Fatigue beyond the mild tiredness that sometimes accompanies a new dose is a common early signal. Hair thinning, which can appear six to twelve weeks into a significant calorie restriction, is another, not caused by the medicine itself but by the nutritional gap it creates when appetite suppression is very strong.
Muscle cramps and weakness, difficulty concentrating, and feeling cold can all point to inadequate intake. Nausea that does not settle within the first week or two of a dose sometimes reflects the stomach being almost completely empty before injection day, which worsens gastric-emptying effects.
People who have been eating only once a day on Mounjaro sometimes report that their energy eventually bottoms out, not from the medicine, but from what they are not eating. One meal, even a substantial one, rarely covers micronutrient needs across a full day.
On the other side of this sits eating too much on Mounjaro, which brings its own set of problems, nausea, reflux and slower progress. The clinical sweet spot is neither extreme. A rough working guide from dietetic practice is to stay above 1,200 calories for women and 1,500 for men, even if appetite would happily settle lower, and to make sure a meaningful proportion of those calories comes from protein. Your prescriber may suggest a more personalised range based on your weight, activity level and medical history.
When total food volume drops, the composition of what remains matters disproportionately. Protein is the priority: it supports muscle preservation, slows gastric emptying (which complements what tirzepatide is already doing), and keeps satiety steadier across the day without relying on appetite suppression alone.
A working target often cited by NHS dietitians is roughly 1.2 to 1.6g of protein per kilogram of bodyweight per day for people losing weight with medication support, more if you are doing resistance exercise, which is worth doing. Foods like bread are not forbidden, but they are low in protein relative to their calorie content, so they should sit around foods that earn their place nutritionally.
Hydration is the other variable that often gets missed. GI side effects (nausea, vomiting, diarrhoea) carry dehydration risk, and that risk climbs when you are already eating and drinking less than usual. Sipping fluids throughout the day, rather than drinking in large volumes, tends to sit better alongside the slower gastric emptying that comes with treatment. The NHS tirzepatide page covers the side-effect profile in full and is worth reviewing if you are unsure what symptoms to watch versus when to contact your prescriber.
Iron, B vitamins and zinc can all drop when variety in the diet shrinks alongside volume. If your intake has been very low for more than a few weeks, a blood test with your GP is sensible. That is something to raise at your next clinical review, or sooner if symptoms are significant. The January 2026 MHRA Drug Safety Update on GLP-1 medicines is also a useful reference if you want to understand the broader side-effect picture, including pancreatitis warning signs that warrant urgent attention.
Three smaller meals tends to work better than two large ones or one enormous one, portions that would have seemed modest before treatment may now feel entirely filling. The practical question is not how little you can manage but how to structure eating so that the calories you do consume actually contain what your body needs.
Prioritise protein at every meal, eggs, fish, chicken, Greek yogurt, legumes, tofu. Add vegetables for volume and fibre. Keep refined carbohydrates in the meal rather than eating them alone, which helps manage blood sugar and avoids the quick hunger that can follow a carb-only snack, even on Mounjaro. Whether food choices matter at all on Mounjaro is a question worth exploring properly, the short answer is that they do.
If you are tracking calories and consistently sitting below 800 a day, tell your prescriber. That is not a failure, it is useful clinical information. Dose timing, meal spacing and appetite management strategies are all within the scope of a good prescriber review. For context on how treatment pricing compares across providers, the Mounjaro cost page covers the UK market honestly. And if you are exploring whether Mounjaro might be right for you, our full Mounjaro guide is the place to start before booking a consultation.
Speak to our prescribers if you have concerns about your appetite or intake on treatment, clinical oversight is part of what private treatment through a regulated service is for, and that conversation is easier to have than most people expect.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.